BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7452948)

  • 1. [Faecal bacterial flora in cirrhotic patients and effects of administration of antibiotics or lactulose (author's transl)].
    Tarao K; Yamazaki R; Ito A; Odagiri S; Fukushima K
    Nihon Shokakibyo Gakkai Zasshi; 1980 Oct; 77(10):1566-74. PubMed ID: 7452948
    [No Abstract]   [Full Text] [Related]  

  • 2. Control of endotoxinemia in liver disease by lactulose and paromomycin.
    Scevola D; Magliulo E; Trpin L; Benzi-Cipelli R; Bernardi R
    Boll Ist Sieroter Milan; 1979 Jul; 58(3):242-7. PubMed ID: 518757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients.
    Riggio O; Varriale M; Testore GP; Di Rosa R; Di Rosa E; Merli M; Romiti A; Candiani C; Capocaccia L
    J Clin Gastroenterol; 1990 Aug; 12(4):433-6. PubMed ID: 2398251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)].
    Leonhardt H; Sanhueza P
    Med Klin; 1978 Jan; 73(2):63-8. PubMed ID: 622058
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects.
    Weber FL; Fresard KM; Lally BR
    Gastroenterology; 1982 Feb; 82(2):213-7. PubMed ID: 7054022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of cirrhotic encephalopathy].
    Thaler H
    Med Chir Dig; 1976; 5(3):149-51. PubMed ID: 1004044
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
    Pirotte J; Guffens JM; Devos J
    Digestion; 1974; 10(6):435-44. PubMed ID: 4448315
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of healthy salmonella carriers with lactulose beta-galactosido-fructose (author's transl)].
    Hoffmann K
    Dtsch Med Wochenschr; 1975 Jun; 100(26):1429-31. PubMed ID: 238823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora.
    Weber FL
    Dig Dis; 1996; 14 Suppl 1():53-63. PubMed ID: 8872452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of salmonella enteritis with special reference to lactulose (author's transl)].
    Knothe H; Knapp G; Meyer M; Polanetzki U; Weber G
    Infection; 1980; 8 Suppl 3():S 294-8. PubMed ID: 6997206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal flora changes after oral antibiotics.
    Daikos G; Kontomichalou P; Bilalis D
    Proc R Soc Med; 1969 Mar; 62(3):260. PubMed ID: 5768344
    [No Abstract]   [Full Text] [Related]  

  • 12. Portal systemic encephalopathy--should lactulose and neomycin be used together.
    Martin AJ
    Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy.
    Bajaj JS; Sikaroodi M; Shamsaddini A; Henseler Z; Santiago-Rodriguez T; Acharya C; Fagan A; Hylemon PB; Fuchs M; Gavis E; Ward T; Knights D; Gillevet PM
    Gut; 2021 Jun; 70(6):1162-1173. PubMed ID: 32998876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactulose.
    Elkington SG
    Gut; 1970 Dec; 11(12):1043-8. PubMed ID: 4929274
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters.
    Uribe-Esquivel M; Moran S; Poo JL; Muñoz RM
    Scand J Gastroenterol Suppl; 1997; 222():49-52. PubMed ID: 9145447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
    Patil DH; Westaby D; Mahida YR; Palmer KR; Rees R; Clark ML; Dawson AM; Silk DB
    Gut; 1987 Mar; 28(3):255-9. PubMed ID: 3570029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy].
    Sala Felis T; Berenguer J; Barrios JM; Gómez J
    Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021
    [No Abstract]   [Full Text] [Related]  

  • 19. [Organization of nocturnal sleep in patients with liver cirrhosis: changes before and after treatment with levodopa and lactulose].
    Bergonzi P; Bianco A; Mazza S; Mennuni G; Zolo P
    Riv Neurol; 1975; 45(1):118-23. PubMed ID: 167416
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions of lactulose and neomycin.
    Conn HO
    Drugs; 1972; 4(1):4-6. PubMed ID: 4637575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.